Eli Casdin is of Sema4 Holdings Corp.. Currently has a direct ownership of 7,593 shares of SMFR, which is worth approximately $2,581. The most recent transaction as insider was on Jun 20, 2024, when has been sold 5,828 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.59K
0% 3M change
86.97% 12M change
Total Value Held $2,581

Eli Casdin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2024
BUY
Exercise of conversion of derivative security
-
5,828 Added 43.42%
7,593 Class A Common Stock
May 02 2023
BUY
Exercise of conversion of derivative security
-
45,454 Added 43.81%
58,290 Class A Common Stock
Apr 27 2022
BUY
Exercise of conversion of derivative security
-
12,836 Added 50.0%
12,836 Class A Common Stock

Also insider at

IPSC
Century Therapeutics, Inc. Healthcare
ABSI
Absci Corp Healthcare
TNYA
Tenaya Therapeutics, Inc. Healthcare
SLGC
SomaLogic, Inc. Healthcare
EQRX
EQRx, Inc. Healthcare
LAB
STANDARD BIOTOOLS INC. Healthcare
EC

Eli Casdin

New York, NY

Track Institutional and Insider Activities on SMFR

Follow Sema4 Holdings Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SMFR shares.

Notify only if

Insider Trading

Get notified when an Sema4 Holdings Corp. insider buys or sells SMFR shares.

Notify only if

News

Receive news related to Sema4 Holdings Corp.

Track Activities on SMFR